Abstract | BACKGROUND: OBJECTIVE: DESIGN: Screening for mutations in POMGnT1. SETTING: Tertiary neuromuscular unit. PATIENT: RESULTS: A homozygous POMGnT1 missense mutation (c.1666G>A, p.Asp556Asn) was identified. Enzyme studies of the patient's fibroblasts showed an altered kinetic profile, less marked than in patients with muscle-eye-brain disease and in keeping with the relatively mild phenotype in our patient. CONCLUSIONS:
|
Authors | Emma M Clement, Caroline Godfrey, Jenny Tan, Martin Brockington, Silvia Torelli, Lucy Feng, Susan C Brown, Cecilia Jimenez-Mallebrera, Caroline A Sewry, Cheryl Longman, Rachael Mein, Steve Abbs, Jiri Vajsar, Harry Schachter, Francesco Muntoni |
Journal | Archives of neurology
(Arch Neurol)
Vol. 65
Issue 1
Pg. 137-41
(Jan 2008)
ISSN: 0003-9942 [Print] United States |
PMID | 18195152
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Dystroglycans
- N-Acetylglucosaminyltransferases
- protein O-mannose beta-1,2-N-acetylglucosaminyltransferase
|
Topics |
- Alleles
- Blotting, Western
- Child
- DNA Mutational Analysis
- Dystroglycans
(metabolism)
- Fibroblasts
(enzymology)
- Genetic Testing
- Humans
- Immunohistochemistry
- Kinetics
- Male
- Muscle, Skeletal
(metabolism, pathology)
- Muscular Dystrophies, Limb-Girdle
(complications, genetics, psychology)
- Mutation
- Mutation, Missense
(genetics)
- Myopia
(etiology)
- N-Acetylglucosaminyltransferases
(genetics)
- Phenotype
|